Information Library
Faster product development - Europe
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
QUINTILES ANNOUNCES CLINICAL RESEARCH PARTNERSHIP WITH THE UNIVERSITY MALAYA MEDICAL CENTRE
July 5, 2010 - Quintiles announces a strategic alliance agreement with the University Malaya Medical Centre (UMMC) as part of its unique Prime Site program - an initiative focused on accelerating the development of new and more effective medicines.
-
Malaysia Prime Site
July 2, 2010
Adam Chasse, Sr. Director, Access to Patients explains the importance of Prime Sites and the impact of our clinical research partnership with the University of Malaya Medical Centre in Malaysia. -
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
-
Clinical – smarter trials, accelerated outcomes
April 2, 2010
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD
Research Triangle Park, NC, December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.
-
QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH
October 26, 2009 - A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide.
-
Validated Biomarker Menu
July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays.
Page 1 of 1 (7 results)
